FdaApplication
NDA 021323
Identifiers
- fda_app_no: NDA021323
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2002-08-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEXAPRO | ESCITALOPRAM OXALATE | EQ 5MG BASE | TABLET;ORAL |
| LEXAPRO | ESCITALOPRAM OXALATE | EQ 20MG BASE | TABLET;ORAL |
| LEXAPRO | ESCITALOPRAM OXALATE | EQ 10MG BASE | TABLET;ORAL |
3 products